104 related articles for article (PubMed ID: 1377928)
1. Comparative effects of a recombinant and a mutein type of granulocyte colony stimulating factor on the growth of Meth-A fibrosarcoma with 5-fluorouracil chemotherapy.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
Biotherapy; 1992; 4(2):81-6. PubMed ID: 1377928
[TBL] [Abstract][Full Text] [Related]
2. Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil.
Moore MA; Stolfi RL; Martin DS
J Natl Cancer Inst; 1990 Jun; 82(12):1031-7. PubMed ID: 1693405
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of host defense by Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice.
Hisadome M; Fukuda T; Terasawa M; Oe T; Takahata H; Goto K; Tsuru S; Nomoto K
Int J Immunopharmacol; 1992 Oct; 14(7):1195-201. PubMed ID: 1280628
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of SPR-901 (RBS) on the decrease of peripheral leukocyte number in 5-fluorouracil-treated mice.
Miyazaki H; Yoshikai Y; Tanaka M; Takeda Y; Takeo S; Nomoto K
Int J Immunopharmacol; 1992 Jan; 14(1):11-7. PubMed ID: 1374741
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
Shi YK; Zhou JC; Feng FY
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
[TBL] [Abstract][Full Text] [Related]
6. Increase in total blood leukocyte count following intranasal administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rabbits with cyclophosphamide-induced leukopenia.
Watanabe Y; Kikuchi R; Kiriyama M; Nakagawa K; Oe J; Nomura H; Maruyama K; Matsumoto M
Biol Pharm Bull; 1995 Aug; 18(8):1084-8. PubMed ID: 8535401
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice.
Maeda M; Watanabe N; Tsuji N; Tsuji Y; Okamoto T; Sasaki H; Akiyama S; Niitsu Y
Jpn J Cancer Res; 1993 Aug; 84(8):921-7. PubMed ID: 7691787
[TBL] [Abstract][Full Text] [Related]
8. In vivo tumor growth enhancement by granulocyte colony-stimulating factor.
Segawa K; Ueno Y; Kataoka T
Jpn J Cancer Res; 1991 Apr; 82(4):440-7. PubMed ID: 1710615
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of ren-shen-yang-rong-tang (Ninjin-youei-to) in mice with drug-induced leukopenia against Pseudomonas aeruginosa infection.
Miura S; Takimoto H; Yoshikai Y; Kumazawa Y; Yamada A; Nomoto K
Int J Immunopharmacol; 1992 Oct; 14(7):1249-57. PubMed ID: 1280629
[TBL] [Abstract][Full Text] [Related]
10. Effect of co-administration of granulocyte colony-stimulating factor on interferon therapy.
Segawa K; Suhara Y; Ueno Y; Kataoka T
Jpn J Cancer Res; 1991 Mar; 82(3):346-50. PubMed ID: 1708757
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human granulocyte colony-stimulating factor accelerates regeneration after T-2 toxin-induced hemopoietic injury and lessens lethality in mice.
Ohtani K; Nanya T; Aoyama Y; Matsunami S; Sekijima M; Kawamura O; Ohtsubo K; Ueno Y
J Toxicol Sci; 1993 Aug; 18(3):155-66. PubMed ID: 7504113
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
Shi YK; Feng FY; Sun Y
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):739-42. PubMed ID: 7541325
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
Matsuzaki G; Li XY; Ohyama Y; Nomoto K
Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
[TBL] [Abstract][Full Text] [Related]
14. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
Scheding S; Media JE; Nakeff A
Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
Fukuda M; Horibe K; Furukawa K
Int J Mol Med; 1998 Oct; 2(4):471-5. PubMed ID: 9857237
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice.
Ishikawa M; Okada Y; Satake-Ishikawa R; Kakitani M; Kawagishi M; Matsuki S; Kusaka M; Asano K
Gen Pharmacol; 1994 May; 25(3):533-7. PubMed ID: 7523237
[TBL] [Abstract][Full Text] [Related]
17. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy.
Schmidberger H; Hess CF; Hoffmann W; Reuss-Borst MA; Bamberg M
Eur J Cancer; 1993; 29A(14):1927-31. PubMed ID: 7506558
[TBL] [Abstract][Full Text] [Related]
19. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
20. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
